BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herzog CA. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2. Clin J Am Soc Nephrol 2016;11:2095-6. [PMID: 27797902 DOI: 10.2215/CJN.09470916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Reinecke H, Jürgensmeyer S, Engelbertz C, Gerss J, Kirchhof P, Breithardt G, Bauersachs R, Wanner C. Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study. BMJ Open 2018;8:e022690. [PMID: 30206088 DOI: 10.1136/bmjopen-2018-022690] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
2 Wetmore JB, Peng Y, Gilbertson DT, Liu J. Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis. Am J Cardiol 2019;123:598-604. [PMID: 30527770 DOI: 10.1016/j.amjcard.2018.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]